Treatment of insomnia in unani medicine

A randomized placebo-controlled trial to evaluate the efficacy of Natul therapy in the treatment of Sahar (Insomnia). - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098601

Enrollment

Registered

2025-12-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

Intervention1: Decoction of Post Khashkhash, Dhania Sabz, Ajwain Khurasani, Gul-e-banafsha, Barge Kahu, Gul-e-Nilofer.: 10 grams of post khashkhash, 14 grams of each remaining ingredient will be taken

Eligibility

Inclusion criteria

Inclusion criteria: Patients clinically diagnosed with insomnia and having an Insomnia Severity Index ISI score between 8 and 21

Exclusion criteria

Exclusion criteria: Acute illnesses. Known case of chronic obstructive pulmonary disease COPD. Sleep disorders associated with diagnosed mental, neurological, or other medical conditions. History of alcohol or drug abuse within the past six months. Patients unwilling to comply with the study protocol.

Design outcomes

Primary

Measure	Time frame
Change in insomnia severity indexTimepoint: Change in insomnia severity index assessed at baseline, 2nd weeks & 4th weeks.	—

Secondary

Measure	Time frame
Change in Short Form 36.Timepoint: Change in Short Form 36 assessed at baseline & 4th weeks.	—

Countries

India

Contacts

Public ContactAbu Talha

State Unani Medical College and Hospital

drbushraaftab@gmail.com8279747882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026